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INTRODUCTION
Evolutionarily conserved transport systems comprise blood and
lymphatic vessels that are lined by distinct endothelial cell types.
Blood vessels allow circulation of blood cells, gas exchange and
delivery of metabolic products to and from tissues. The lymphatic
system consists of blind-ended vessels that return fluid and
macromolecules from interstitial tissue space back into blood
circulation, while serving as a conduit for the development and
transport of lymphoid cells (Tammela and Alitalo, 2010). During
embryogenesis, blood vessels arise from endothelial cell progenitors
that coalesce and differentiate into arteries and veins (Cleaver and
Krieg, 2010). Subsequently, new blood vessels sprout from pre-
existing ones by angiogenesis (Poole and Coffin, 1989). Later,
lymphatic progenitors are specified from endothelial cells in the
embryonic cardinal vein (Srinivasan et al., 2007), which sprout to
form lymphatic vessels.
Vascular endothelial growth factor C (Vegfc) is the central
regulator of lymphatic development (Tammela and Alitalo, 2010).
Vegfc is expressed as a pro-peptide and cleaved to yield a secreted
factor that acts on lymphatic endothelial cells (Joukov et al., 1997).
Ectopic vegfc expression can cause lymphatic hyperplasia (Jeltsch
et al., 1997) and mice or zebrafish lacking vegfc fail to develop
lymphatic vessels and exhibit a block in primary sprouting of
lymphatic progenitors from the cardinal vein (Karkkainen et al.,
2004; Küchler et al., 2006; Yaniv et al., 2006). Vegfc functions
primarily through binding and activation of the Vegfr3 receptor
tyrosine kinase (Joukov et al., 1996) (hereafter referred to as Flt4),
which is specifically expressed in both blood vascular and
lymphatic endothelial cells (Kaipainen et al., 1995; Kukk et al.,
1996). While Vegfc can also activate Vegfr2, a Flt4-specific form of
Vegfc can induce lymphatic hyperplasia (Veikkola et al., 2001).
Vegfc and its receptor are also important for lymphatic homeostasis
in adults. Notably, mutations in human FLT4 that reduce kinase
activity cause congenital lymphedema (Karkkainen et al., 2000).
Thus, Vegfc/Flt4 signaling is essential for lymphatic development
and homeostasis in vertebrates.
In addition to their roles in lymphatic development, Vegfc and
Flt4 have been implicated in angiogenesis. In the circulatory
system, flt4 is expressed in actively sprouting endothelial cells,
where it becomes restricted to tip cells (Siekmann and Lawson,
2007; Tammela et al., 2008) and loss of flt4 in mouse or zebrafish
causes defects in angiogenesis (Covassin et al., 2006; Dumont et
al., 1998; Tammela et al., 2011; Tammela et al., 2008).
Interestingly, flt4 is a central target of repression by the Notch
pathway during angiogenesis. Notch activation downregulates flt4
expression (Lawson et al., 2001), whereas Notch deficiency causes
increased and ectopic flt4 expression (Siekmann and Lawson,
2007; Tammela et al., 2008). Furthermore, reduced flt4 signaling
attenuates the hyperangiogenic phenotype associated with loss of
Notch (Benedito et al., 2012; Siekmann and Lawson, 2007).
However, the role of vegfc during angiogenesis is less clear.
Although transgenic overexpression of Vegfc in mice can induce
lymphatic hyperplasia (Jeltsch et al., 1997), it also induced
angiogenesis, which was restricted to embryonic blood vessels
that expressed Flt4 and was caused by overexpressing Vegfc in
endothelial cells themselves (Lohela et al., 2008). Furthermore,
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SUMMARY
Vascular endothelial growth factor C (Vegfc) is a secreted protein that guides lymphatic development in vertebrate embryos. However,
its role during developmental angiogenesis is not well characterized. Here, we identify a mutation in zebrafish vegfc that severely
affects lymphatic development and leads to angiogenesis defects on sensitized genetic backgrounds. The um18 mutation prematurely
truncated Vegfc, blocking its secretion and paracrine activity but not its ability to activate its receptor Flt4. When expressed in
endothelial cells, vegfcum18 could not rescue lymphatic defects in mutant embryos, but induced ectopic blood vessel branching.
Furthermore, vegfc-deficient endothelial cells did not efficiently contribute to tip cell positions in developing sprouts. Computational
modeling together with assessment of endothelial cell dynamics by time-lapse analysis suggested that an autocrine Vegfc/Flt4 loop
plays an important role in migratory persistence and filopodia stability during sprouting. Our results suggest that Vegfc acts in two
distinct modes during development: as a paracrine factor secreted from arteries to guide closely associated lymphatic vasculature and
as an autocrine factor to drive migratory persistence during angiogenesis.
KEY WORDS: Vegfc, Angiogenesis, Lymphatic, Zebrafish
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vegfc is normally expressed in endothelial cells during
development (Covassin et al., 2006; Tammela et al., 2008),
suggesting that a Vegfc/Flt4 autocrine loop might be important for
angiogenesis.
Here, we describe a zebrafish mutant, um18, that fails to develop
lymphatic vessels and displays mild angiogenesis defects on a
sensitized genetic background. The um18 mutation caused
premature truncation of zebrafish Vegfc, which hindered its
secretion but not its ability to activate Flt4. Vegfcum18 could not
rescue lymphatic formation, but caused ectopic blood vessel
branching when expressed in endothelial cells. Additionally, vegfc-
deficient cells displayed autonomous defects in tip cell potential,
suggesting an important autocrine role in angiogenesis.
Computational modeling and time-lapse analysis of angiogenesis
in Vegfc-deficient embryos suggested an important role in
maintaining filopodia stability and migratory persistence. Together,
our results suggest that Vegfc signals via distinct autocrine and
paracrine mechanisms to pattern blood and lymphatic vessels,
respectively.
MATERIALS AND METHODS
Zebrafish handling and maintenance
Zebrafish were maintained in accordance with approved University of
Massachusetts Medical School IACUC protocols. Tg(fli1a:egfp)y1, kdrly17
and Tg(kdrl:rasmcherry)s896 lines have been described elsewhere (Covassin
et al., 2006; Herbert et al., 2009; Lawson and Weinstein, 2002).
Antibodies
A glutathione-S-transferase (GST)-fusion protein containing the first 225
amino acids of zebrafish Fli1b was expressed in BL21 E. coli, purified on
glutathione-Sepharose beads (GE Healthcare) and cleaved from the GST
using PreScission Protease (GE Healthcare). Flt4 peptide (NH2-
CASDELERFEHKHRGA; New England Peptide, Gardner, MA, USA) or
Fli1b protein was used to raise rabbit polyclonal antisera (Capralogics,
Hardwick, MA, USA).
Identification and cloning of um18
N-ethyl-N-nitrosourea (ENU) mutagenesis and haploid screening were
performed as described previously (Covassin et al., 2009), except that
embryos were screened for loss of primordial hindbrain channel (PHBC).
F1 females were outcrossed to TL males and progeny from individual F2
incrosses were assayed for PHBC formation at 26 hours post-fertilization
(hpf) and for thoracic duct (TD) at 7 days post-fertilization (dpf). Embryos
that failed to form both were designated mutants and used for linkage
analysis as described previously (Lawson et al., 2003). To assess linkage to
vegfc, we used CA markers (Z25069, Z11618, Z26040, Z24128) and a
single-nucleotide polymorphism (SNP) in the vegfc 3 UTR (see
supplementary material Table S1 for primer sequences) that creates an XcmI
site. The um18 mutation was identified by sequencing PCR products
encompassing vegfc exons amplified from genomic DNA. To genotype the
vegfcum18 allele, we used a customized TaqMan SNP assay (Applied
Biosystems). The kdry17 allele was genotyped as previously (Covassin et
al., 2006).
Phenotypic analysis
General morphology and circulation were assessed using transmitted light
on an MZ FLIII stereomicroscope (Leica). Images were recorded on an
AxioCam MRc digital camera (Zeiss). Vascular morphology in
Tg(fli1a:egfp)y1 embryos was imaged using a Leica DMIRE2 confocal
microscope (HC PL APO 20×/0.70 CS objective). Microangiography was
performed as described previously (Isogai et al., 2001). Intersomitic vessel
(ISV) connections were scored as arterial or venous based on flow direction
and counted from the fifth to the last somite at 72 hpf. ISV length was
determined in live or fixed embryos subjected to GFP immunostaining as
described (Covassin et al., 2006). To quantify endothelial nuclei, embryos
were fixed in 2% paraformaldehyde overnight at 4°C and permeabilized
with 0.5% Triton X-100 in PBS for 30 minutes. Samples were incubated in
blocking solution (PBS containing 0.1% Triton X-100, 10% normal goat
serum, 1% BSA, 0.01% sodium azide), followed by Fli1b antiserum at
1:1000 in blocking solution. Embryos were washed four times for
15 minutes each, followed by an overnight wash at 4°C and staining with
goat anti-rabbit Alexa-Fluor 568 antibody (Molecular Probes) at 1:1000 in
blocking solution. We counted nuclei in three adjacent ISVs and dorsal
longitudinal anastomotic vessels in embryos injected with 15 ng control
MO or Dll4 MO (Siekmann and Lawson, 2007). Ectopic branching points
were counted for the same ISVs.
Analysis of Vegfc knockout mouse embryos
Mouse studies were approved by the Committee for Animal Experiments of
the District of Southern Finland. Vegfc+/lacZ mice are described elsewhere
(Karkkainen et al., 2004). Embryos were staged according to Edinburgh
Mouse Atlas criteria, harvested at E9.5, fixed in 4% paraformaldehyde,
washed in PBS and processed for whole-mount staining as described
previously (Tammela et al., 2011). Endomucin staining (sc-65495, Santa
Cruz), followed by Alexa Fluor 488-conjugated anti-rat antibody
(Molecular Probes), was used to visualize blood vessels in the embryos.
Samples were mounted with Vectashield mounting medium (Vector Labs)
containing 4,6-diamidino-2-phenylindole (DAPI) (H-1200, Vector
Laboratories) and analyzed with a confocal microscope (Zeiss LSM 510
Meta, 10× objective with NA 0.45). Three-dimensional projections were
digitally reconstructed from confocal z-stacks. Branching points in cranial
vessels and ISV length between somites 14 and 16 were manually counted
using ImageJ software (NIH; version 1.43r). Statistical analysis was carried
out with PASW Statistics 18.0 software (SPSS). For comparison of means
a two-way ANOVA test followed by Tukey's HSD post-hoc test were used.
Data are presented as mean ± s.e.m. with statistical significance indicated.
Cloning and plasmid construction
Zebrafish vegfc, vegfcum18 and vegfcss middle entry clones (pMEvegfc,
pMEvegfcum18, pMEvegfcss) lacking stop codons were constructed by
Gateway cloning as described (Villefranc et al., 2007) (see supplementary
material Table S1 for primer sequences). pMEvegfc, pMEvegfcum18,
pMEvegfss or pMEegfp3 (Villefranc et al., 2007) were used in LR reactions
with pDestTol2pA, p5Efliebs and p3E-2Amcherry to yield
pTol2fliebs:vegfc-2Amcherry, pTol2fliebs:vegfcum18-2Amcherry,
pTol2fliebs:vegfcss-2Amcherry and pTol2fliebs:egfp-2Amcherry. To
generate mammalian expression constructs, pMEvegfc or pMEvegfcum18
were used in an LR reaction with pCSDest2 (Villefranc et al., 2007) and
p3E-2Amcherry to produce pCSvegfc-2Amcherry and pCSvegfcum18-
2Amcherry. pMT-Ex-zfVegfc-wt and pMT-Ex-zfVegfcum18 were constructed
by cloning a BamHI/NotI-cleaved PCR product of zebrafish vegfc into
pMTBiP-V5His-C (Invitrogen), which was modified to include a
hygromycin cassette and a frameshift mutation between the BiP signal
peptide and the multiple cloning site such that the 5-GAT-3 from the BglII
site codes for an aspartic acid residue. A human VEGFCum18 middle entry
vector was constructed as above using the primers listed in supplementary
material Table S1. pME-VEGFCum18 was LR cloned into pCSDest
(Villefranc et al., 2007) to create pCS-VEGFCum18. To generate pCSflt4-
ha, we created pMEflt4 lacking its endogenous stop codon (supplementary
material Table S1). pMEflt4 and p3E-HA were LR cloned into pCSDest2 to
give pCS-flt4-ha (Villefranc et al., 2007).
Transient transgenic vegfc expression
We co-injected 25 pg pTol2 constructs into one-cell stage embryos with 25
pg tol2 transposase mRNA. To assay ISV defects, we injected wild-type
Tg(fli1a:egfp)y1 embryos and counted ectopic Cherry-positive vessel
branches in six hemisegments at 30 hpf. For rescue experiments, we injected
embryos from an incross of Tg(fli1a:egfp)y1;vegfc+/um18 carriers. Injected
embryos with Cherry-positive vessels were scored for TD formation at 5
dpf and genotyped for um18.
Production of Vegfc-conditioned media
S2 cells were transfected with either pMT-Ex-zfVegfc or pMT-Ex-
zfVegfcum18 and stable cell pools were created according to standard
protocols. To produce protein, cells were induced with 1 mM CuSO4 and
conditioned cell supernatant was harvested 3.5 days post-induction.
RESEARCH ARTICLE Development 140 (7)
D
E
V
E
LO
P
M
E
N
T
Yolk membrane angiogenesis assay
Four nanoliters of Vegfc-, Vegfcum18- or negative control-conditioned
medium was injected into the perivitelline space of anesthetized 48-hpf
Tg(fli1a:egfp)y1 embryos as previously (Nicoli et al., 2009). Ectopic
subintestinal vessels (SIVs) were visualized by confocal microscopy and
counted at 3.5 dpf. For xenografts, NIH3T3 cells were transfected with 1 μg
pCSvegfc-2Amcherry or pCSvegfcum18-2Amcherry using Lipofectamine
2000 (Invitrogen), grown for 48 hours, and subjected to fluorescence-
activated cell sorting (FACS) to isolate expressing cells. Approximately
6000 Cherry-positive cells were diluted in Matrigel (Sigma) and injected
into the perivitelline space as above. Xenografts were imaged at 2 days post-
engraftment by confocal microscopy. Imaris (Bitplane) was used to quantify
the relative number of vegfc-expressing cells (red voxels) and vessels (green
voxels) as described previously (Nicoli et al., 2010).
Analysis of VEGFC secretion
NIH3T3 cells were transfected with 1 μg pSport6CMV-VEGFC (Open
Biosystems) or pCS-VEGFCum18 using Lipofectamine 2000. Medium was
collected at 30 and 72 hours post-transfection and concentrated using
centrifugal filter units (Ultragel 10K, Millipore) while cells were lysed in
RIPA buffer (150 mM NaCl, 50 mM Tris pH 8.0, 1% NP40, 0.1% SDS)
containing protease inhibitors (Complete Mini, Roche). Blots were probed
with a polyclonal human anti-VEGFC antibody (Joukov et al., 1996),
stripped and reprobed with a monoclonal anti-Tubulin antibody (kindly
provided by Dr Michael Green, University of Massachusetts Medical
School, Worcester, MA, USA).
Flt4 activation assay
NIH3T3 cells were transiently transfected with 1 μg pCSflt4-HA. After
24 hours, cells were starved for 24 hours and stimulated for 7 minutes with
zebrafish Vegfc-, Vegfcum18- or negative control-conditioned medium. Cells
were lysed in RIPA buffer containing phosphatase and protease inhibitors
and used for immunoprecipitation using zebrafish Flt4 polyclonal antibody.
Immunoprecipitates were subjected to SDS-PAGE and western blotting.
Blots were probed with a monoclonal antibody against phosphotyrosine
(4G10 clone, Millipore), stripped, and reprobed with monoclonal anti-HA
antibody (BABCO).
Mosaic analysis
Transplantations were performed as described (Covassin et al., 2009).
Donors were injected with control (5 ng) or Vegfc MO (2.5 and 5 ng).
Alternatively, cells were taken from embryos derived from an incross of
Tg(fli1:egfp)y1;vegfcum18 carriers and donors were genotyped following
transplantation. At 30 hpf, the location of donor cells in host vessels was
calculated and analyzed using a Fisher’s exact test as described previously
(Nicoli et al., 2012).
Computational modeling
The memAgent-Spring model (MSM) (Bentley et al., 2008; Bentley et al.,
2009) was used to investigate four possible autocrine effects of Vegfc/Flt4
signaling to identify the best match to experimental data. The MSM has
previously been calibrated to match wild-type sprouting data; therefore,
Vegfc/Flt4 signaling is encompassed in existing parameters. We modeled
the loss of Vegfc by a reduction in an existing model parameter. For each
mechanism simulated, a single parameter k was created to control the
strength of this loss, under four different conditions as follows:
Type 1 – Vegfc directly affects Dll4 and migration. (a) Vegfc/Flt4 acts to
improve signaling via Vegfr2 by a constant amount. For MO, k is a small
fixed amount subtracted from the total local VEGF of a memAgent. (b)
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Fig. 1. vegfcum18 mutants display defects in
vein and lymphatic vessel development.
(A) Linkage map of markers on zebrafish
chromosome 1 used in this study. (B) um18
mutation in vegfc exon 4. Box indicates the
Gln202 to stop transition. (C) Vegfc domains and
amino acid alignment near the um18 truncation.
Hs, human; Mm, mouse; Dr, zebrafish. (D,E) (Left)
Transmitted light images of embryos at 30 hpf.
(Middle) Confocal micrographs of head blood
vessels at 30 hpf. Primordial hindbrain channel
(PHBC) is indicated by arrows. (Right) Confocal
micrographs of trunk vessels at 5 dpf. Thoracic
duct (TD) is indicated by arrowheads. Wild-type
(D) and vegfcum18 mutant (E) Tg(fli1a:egfp)y1
siblings are shown. (F-H) Confocal micrographs
of Tg(fli1a:egfp)y1 vegfcum18 mutant embryos co-
injected with 25 pg tol2 transposase mRNA and
25 pg (F) pTol2-fli1ebs:egfp-2Amcherry, (G) pTol2-
fli1ebs:vegfcum18-2Amcherry or (H) pTol2-
fli1ebs:vegfc-2Amcherry. Yellow arrowheads
indicate arterial endothelial cells expressing
mCherry. Bracket with asterisk indicates absence
of TD. White arrows indicate TD rescue. (D-H)
Lateral view, anterior to the left, dorsal up. 
(I) Percentage of embryos showing TD of the
indicated genotype injected with the indicated
constructs. Values are the average of three
independent experiments. *P<0.05; N.S., not
significant; error bars indicate s.e.m.  DA, dorsal
aorta; PCV, posterior cardinal vein. Scale bars:
250 μm in D,E left; 50 μm in D,E middle; 25 μm
in D,E right, F-H.
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Vegfc/Flt4 signaling proportionally reduces Vegfr2  signaling. For MO, k is
the proportion of the total local VEGF of a memAgent removed.
Type 2 – Vegfc indirectly affects Dll4 but directly affects migration. (a)
Vegfc/Flt4 induces initiation of filopodia. For MO, k is the probability of a
filopodia extending in response to VEGF stimulation. (b) Vegfc/Flt4
promotes persistence and stability of filopodia. For MO, k is the probability
of a filopodium to randomly begin retracting.
In each case, k was directly calibrated using a sensitivity analysis to
match transplant data using the approach below (see supplementary material
Table S2 for parameter values). If a matching parameter could be found,
each mechanism was then tested in a simulation modeling the dorsal
migration of a tip cell through the somites, as defined below. Type 1b and
Type 2b matched the chimeric data, but only Type 2b was able to match the
ISV extension data.
Modeling chimeric transplant data
To model transplant data, embryos were considered as a single simulation
of a vessel comprising ten cells in a continuous gradient of Vegfa, linearly
increasing in the y-axis. A simple uniform, random contribution of Vegfc-
deficient cells to the vessel was capped at a maximum of 50% MO cells to
control cells. Hence, some ‘embryos’ could have zero MO cells and a
maximum of five in random positions. Only embryos that contained at least
one MO cell were counted. The same method was used to quantify chimeric
simulations as was used experimentally.
Modeling ISV tip cell extension
To simulate ISV migration, a version of the model was implemented to
focus on measuring the distance reached by a traveling tip cell. In this case,
Dll4/Notch signaling was switched off as the selection process was assumed
to have occurred already and a tip cell selected. A linear, increasing gradient
of Vegfa was created in a column of three-dimensional space, 10 μm wide
in the center above the tip cell, reaching up for 100 μm. Concentration
settings were as previously described (Bentley et al., 2009): 0.04 molecules
of VEGF multiplied by the y-axis position in each grid site. This assumes
that VEGF is not accessible in somites to the left or right of the column and
thus the tip will not grow into somite space.
Time-lapse analysis
Tg(fli1a:egfp)y1 embryos were injected with 5 ng control or Vegfc MO and
mounted in agarose at 16 hpf. Images of control and morphant embryos
were captured in parallel on a LSM7 MP laser-scanning microscope (Zeiss)
equipped with a Chameleon Ti:Sapphire pulsed laser (Coherent) every 5
minutes over 8 hours using ZEN 2009 software with the Multi-time macro
(Zeiss). Time-lapse series were loaded into ImageJ to analyze ISV sprouting
and filopodial extension/retraction. ISV length (from the base of the dorsal
aorta to the leading edge of the ISV) and filopodia length were measured
manually in each frame using ImageJ. We measured the lengths of at least
ten filopodia from five separate embryos at 5-minute intervals for a 60
minute span. Filopodia measurements were made on ISVs of comparable
length in control- and Vegfc MO-injected embryos. For ISV length, we
limited analysis to ISVs that were between 3 and 6 μm within the first few
movie frames. We normalized the starting time of each ISV sprout to their
first detectable length and recorded length every 5 minutes for a total of
300 minutes. For ISV forward and retraction rates, we calculated the change
in distance between successive time points from 0 to 30 μm in length for 16
ISVs from eight embryos (control MO) or 17 ISVs from six embryos (Vegfc
MO). Negative (retraction) and positive (forward) values for each ISV were
analyzed for frequency and averaged. Statistical significance was measured
using a paired t-test (ISV length) or a Wilcoxon test (retraction/forward
rates).
RESULTS
A truncated form of vegfc perturbs lymphatic
development
A screen for zebrafish embryos lacking a primordial hindbrain
channel (PHBC) (supplementary material Fig. S1) identified the
um18 mutant, which is linked to the vegfc locus (Fig. 1A). Analysis
of vegfc coding sequence in um18 mutants revealed a CAA
(Gln202) to TAA (stop) transition (Fig. 1B) that truncates Vegfc 13
amino acid residues upstream of a conserved cleavage site
recognized by the proprotein convertase furin (Fig. 1C) (Joukov et
al., 1997; Siegfried et al., 2003). Despite the presence of a premature
stop codon, we did not observe a decrease in vegfc transcript levels
in mutant embryos (data not shown). At 30 hpf, wild-type and
mutant siblings were generally indistinguishable (Fig. 1D,E, left).
However, vegfcum18 mutants displayed a partially penetrant defect in
PHBC formation (Fig. 1D,E, middle; supplementary material Table
S3), which recovered by 40 hpf (data not shown), and fully
penetrant defects in lymphatic development. Both heterozygous and
homozygous vegfcum18 mutant embryos failed to form a thoracic
duct (TD), which is the first lymphatic vessel in zebrafish embryos,
at 5 dpf (Fig. 1D,E, right; supplementary material Table S3, Fig.
S2). We detected vegfcum18/+ carriers at expected frequencies in
adults, suggesting that they could recover from this defect (data not
shown). We also noted loss of parachordal lymphangioblasts, which
give rise to the TD (Küchler et al., 2006; Yaniv et al., 2006), at 2 dpf
in vegfcum18 mutant and heterozygous embryos (supplementary
material Fig. S3A-E). In addition, vegfcum18 mutants had fewer
intersomitic vein connections than wild-type siblings
(supplementary material Fig. S3F-H and Table S4), suggesting an
early defect in venous sprouting of lymphatic progenitors.
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Fig. 2. vegfcum18 enhances angiogenesis defects in kdrly17 mutant
embryos. (A-D) Confocal micrographs of trunk blood vessels in
Tg(fli1a:egfp)y1 (A) wild-type, (B) vegfcum18 mutant, (C) kdry17 mutant and
(D) kdry17 vegfcum18 double-mutant zebrafish embryos at 30 hpf. Arrows
indicate intersomitic vessels (ISVs). Anterior is to the left, dorsal is up. 
(E) ISV length in embryos of the indicated genotype at 30 hpf. Values are
the average from two clutches of embryos. *P<0.05; N.S., not significant;
error bars indicate s.e.m. DA, dorsal aorta; PCV, posterior cardinal vein.
Scale bar: 50 μm.
D
E
V
E
LO
P
M
E
N
T
To confirm that defects in um18 mutants were due to loss of
vegfc, we performed rescue experiments. Since vegfc is normally
expressed in the dorsal aorta (Covassin et al., 2006), we drove
transgenic endothelial expression using an enhancer from the fli1a
gene (Villefranc et al., 2007). To visualize expressing cells, vegfc
coding sequences were fused to mcherry separated by a viral 2A
peptide sequence in order to express both proteins (Provost et al.,
2007). Mutant embryos expressing egfp-2Amcherry or vegfcum18-
2Amcherry in arterial endothelial cells failed to form a TD
(Fig. 1F,G,I). By contrast, vegfc-2Amcherry rescued TD formation
in vegfcum18 mutants (Fig. 1H,I). Interestingly, a furin-resistant form
of Vegfc (Vegfcss), which prevents its cleavage and retains the C-
terminus, can partially rescue lymphatic formation in vegfcum18
mutants (supplementary material Fig. S4A,B). Together, these
observations suggest that the C-terminal domain of Vegfc is
essential for lymphatic development.
The vegfcum18 mutation has a weak effect on
angiogenesis
Morpholino (MO)-mediated knockdown of zebrafish Vegfc or Flt4
causes a mild, partially penetrant block in intersomitic vessel (ISV)
formation (Covassin et al., 2006). Furthermore, in Vegfc-deficient
mouse embryos at E9.5, we observed decreased branching of cranial
vessels as well a shortening of ISVs (supplementary material Fig.
S5A,B), similar to zebrafish embryos injected with Vegfc MO
(supplementary material Fig. S5C-F), confirming an important
conserved role for vegfc in developmental angiogenesis. However,
ISVs appeared normal in vegfcum18 mutants, suggesting that this
truncated form of Vegfc might be sufficient for angiogenesis. To
further determine the effect of this mutation on angiogenesis, we
assessed ISV formation in vegfcum18 mutant embryos in which this
process was mildly inhibited or enhanced.
Zebrafish embryos mutant for kdrly17, a zebrafish vegf receptor 2
ortholog, show variable ISV defects that are enhanced by reducing
flt4 (Covassin et al., 2009; Covassin et al., 2006). We generated
Tg(fli1a:egfp)y1 zebrafish that were heterozygous for kdrly17 and
vegfcum18 and assessed ISV length in their progeny. In vegfcum18/um18
homozygous mutant embryos with wild-type kdrl, ISV length was
normal (Fig. 2A,B,E). However, we noted a slight and significant
decrease in ISV length in kdrl+/y17;vegfc+/um18 double-heterozygous
embryos that was further enhanced by loss of both copies of wild-
type vegfc (Fig. 2E). ISVs were significantly shorter in kdry17/y17
mutant embryos that were wild-type for the vegfc locus (Fig. 2C,E),
with a progressive decrease in kdrly17/y17;vegfc+/um18 (Fig. 2E) and
kdrly17/y17;vegfcum18/um18 double-mutant embryos (Fig. 2C-E). We
also observed ISVs in vegfcum18 embryos lacking the Notch ligand,
delta-like 4 (dll4), which causes increased ISV endothelial cell
number and branching (Leslie et al., 2007; Siekmann and Lawson,
2007) (Fig. 3A,B,G,H). These defects were similar in vegfcum18/+
heterozygous embryos lacking dll4 (Fig. 3C,D), although slightly
less severe (Fig. 3G,H). Likewise, vegfcum18 homozygous mutant
embryos displayed milder increases in branching and no increase
in cell number following Dll4 knockdown when compared with
wild-type siblings (Fig. 3B,E-H). Taken together, these observations
suggest that the vegfcum18 mutation has a mild effect on ISV
formation that is evident on a sensitized genetic background.
Vegfcum18 is not efficiently secreted
To investigate the effect of the um18 truncation on the Vegfc protein,
we first determined whether Vegfcum18 could activate Flt4. We
generated conditioned medium from Drosophila S2 cells expressing
either Vegfc or Vegfcum18 fused to the BiP secretion signal to reduce
possible effects of the C-terminal truncation on secretion. In cells
expressing zebrafish Flt4, both Vegfc- and Vegfcum18-conditioned
media induced receptor tyrosine phosphorylation to similar levels
(Fig. 4A). Furthermore, injection of Vegfc- or Vegfcum18-
conditioned medium into the perivitelline space of zebrafish
embryos caused similar levels of ectopic subintestinal vessel (SIV)
formation, whereas mock conditioned medium did not (Fig. 4B-E).
We next examined the effect of um18 on Vegfc secretion. Since
an appropriate antibody against zebrafish Vegfc was not available,
we used the human equivalent of Vegfcum18 (VEGFCum18). In this
case, constructs contained the native VEGFC secretion signal. We
detected both unprocessed and processed forms of VEGFC in
lysates and medium from transfected cells (Fig. 4F). By contrast,
VEGFCum18 accumulated in cell lysates and was not in the medium
at 30 hours post-transfection (Fig. 4F,G), although it was detectable
by 72 hours (data not shown). We did not detect changes in protein
stability caused by the loss of the C-terminal domain in these cases
(supplementary material Fig. S6A,B). Interestingly, the furin-
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Fig. 3. vegfcum18 partially rescues loss of dll4.
(A-F) Two-photon micrographs of trunk blood vessels
in fixed Tg(fli1a:egfp)y1 zebrafish embryos at 48 hpf
immunostained for Fli1b. Anterior is to the left, dorsal is
up. Yellow arrowheads indicate endothelial nuclei. Red
arrows indicate ectopic vessel branches. Wild-type
(A,B), vegfcum18/+ (C,D) and vegfcum18/um18 (E,F) embryos
were injected with 15 ng control MO (A,C,E) or 15 ng
Dll4 MO (B,D,F). (G,H) Quantification of (G) nuclei and
(H) ectopic branches across three ISVs in MO-injected
embryos of the indicated genotype. Values are the
average of three experiments. *P<0.05; N.S., not
significant; error bars indicate s.e.m. DA, dorsal aorta;
PCV, posterior cardinal vein. Scale bar: 50 μm.
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resistant form of Vegfc that is capable of partially rescuing vegfcum18
lymphatic defects is secreted, despite its inability to be cleaved
(supplementary material Fig. S4B,C). To further investigate the
effect of the observed secretion defect in vivo, we assessed the
ability of xenografted cells expressing zebrafish vegfcum18 to induce
neovascularization in zebrafish embryos. At 2 days post-graft, cells
expressing wild-type Vegfc-2Amcherry were highly vascularized
whereas those expressing Vegfcum18-2Amcherry were not (Fig. 4H-
J). Together, these observations suggest that the um18 mutation in
Vegfc prevents its efficient secretion, but not its ability to activate
Flt4.
An endothelial cell-autonomous role for Vegfc
during angiogenesis
vegfc is expressed in the hypochord, which lies adjacent to the
dorsal aorta, as well as in aortic endothelial cells themselves
(Covassin et al., 2006). We further find that vegfc is expressed in
ISV endothelial cells as they sprout from the aorta (supplementary
material Fig. S6C), suggesting that vegfc might play an endothelial
cell-autonomous role during angiogenesis. To investigate this
possibility, we first determined the effect of Vegfc and Vegfcum18
on ISVs by overexpressing them in endothelial cells. Transient
endothelial expression of either vegfc or vegfcum18 in ISVs induced
ectopic ISV branching into the horizontal myoseptum, whereas
egfp-2Amcherry did not (Fig. 5A-D). Although vegfcum18 elicited a
more variable effect, this difference was not statistically significant
(Fig. 5D). This effect is in contrast to the inability of vegfcum18 to
rescue lymphatic development (see Fig. 1G,I).
We next determined the endothelial cell-autonomous effect of
vegfc deficiency on ISV growth by performing mosaic analysis. We
transplanted cells from donor Tg(fli1a:egfp)y1 embryos injected with
5 ng Vegfc or control MO, or derived from an incross of vegfcum18
heterozygous carriers, into Tg(kdrl:rasmcherry)s896 host embryos
and assessed their positions in trunk blood vessels at 30 hpf. Control
donor endothelial cells contributed to all trunk blood vessel
positions with relatively equal frequency (Fig. 5E,G). By contrast,
vegfc morphant cells displayed less frequent contribution to both
the distal tip cell position and posterior cardinal vein than control
morphant cells (Fig. 5F,G). Although we noted a similar trend in
the behavior of vegfcum18 mutant cells, the differences were not
statistically significant (Fig. 5H). Together, these observations
demonstrate that vegfc acts in an endothelial cell-autonomous
manner to promote ISV growth.
Vegfc is required for persistent forward migration
during angiogenesis
To investigate cellular mechanisms that might be affected by a
putative Vegfc/Flt4 autocrine loop, we incorporated these signals
into a previously described agent-based computational model
(Bentley et al., 2008; Bentley et al., 2009). We then simulated
sprouting with Vegfc acting in two possible ways: (1) through a
direct effect on Notch signaling and dll4 levels or (2) through a
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Fig. 4. The um18 mutation affects Vegfc secretion. 
(A) Western blot (W.B.) of Flt4 immunoprecipitates (I.P.) from cells
treated with the indicated conditioned medium (CM), probed
with antibodies against phosphotyrosine (pTyr) and zebrafish
Flt4. (B) Quantification of ectopic subintestinal vessels (SIVs) in
embryos injected with the indicated CM. Values are the average
of three experiments. (C-E) Confocal micrographs of SIVs
(arrowheads) in Tg(fli1a:egfp)y1 embryos at 3.5 dpf following
perivitelline injections with (C) Vegfc CM, (D) Vegfcum18 CM or (E)
mock CM. Arrows indicate ectopic SIVs. (F) Western blots probed
with the indicated antibodies. Cell lysates and media from
NIH3T3 cells transiently expressing human VEGFC or VEGFCum18.
Arrow indicates processed secreted form of wild-type VEGFC. 
(G) Quantitation of western blots in F. Values are the average of
three experiments. A.U., arbitrary units. (H,I). Confocal image of
xenografts in 4.5-dpf Tg(fli1a:egfp)y1 embryos expressing (H)
Vegfc-P2Amcherry or (I) Vegfcum18-P2Amcherry (pseudocolored
red). (J) Quantification of vascular density in xenografts from
three experiments. (C-E,H,I) Anterior is to the left, dorsal is up.
*P<0.05; N.S., not significant; error bars indicate s.e.m. Scale bars:
50 μm in C-E; 10 μm in H,I.
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direct effect on the migratory apparatus, with indirect effects on
Notch. Only the latter mechanism yielded an output similar to both
the experimentally derived transplantation and ISV length data.
Simulating a direct effect on Notch failed to recapitulate ISV growth
defects, although it could mimic the transplantation data (Fig. 6A;
supplementary material Table S2 and Fig. S7A). In particular, the
experimental data could be matched by specifically destabilizing
filopodia in vegfc-deficient cells. Accordingly, a higher chance of
random filopodia retraction led to a migratory defect in which vegfc-
deficient cells lagged behind control cells in simulations of growing
ISVs (Fig. 6A; supplementary material Movies 1, 2). Cells lacking
vegfc also showed a moderately reduced ability to contribute to the
tip cell position in competition simulations, consistent with mosaic
analyses (supplementary material Table S2 and Movies 3, 4). These
results suggest that a decrease in filopodia persistence might cause
slower ISV growth rates in Vegfc-deficient embryos.
To test the simulation predictions, we performed two-photon
time-lapse analysis of ISVs at 5-minute intervals in Tg(fli1a:egfp)y1
embryos injected with 5 ng control or Vegfc MO. We focused on the
first few hours of ISV growth to eliminate secondary effects
resulting from ISVs being at different positions relative to
surrounding pro-angiogenic growth factors (e.g. Vegfa) in control
and Vegfc-deficient embryos at later time points. This analysis
revealed that ISVs grew more slowly in embryos injected with
Vegfc MO, which is qualitatively consistent with growth curves
generated by the simulations (Fig. 6A,B). We also noted a slight
reduction in the average time of filopodia persistence in vegfc-
deficient embryos (13.27 minutes in control MO-injected embryos
versus 10.14 minutes in vegfc-deficient embryos; Fig. 6C) as
predicted by the simulations, although this fell just under the cut-off
for statistical significance (P=0.0501). We observed that early ISV
growth was characterized by both forward migration and retraction
back towards the dorsal aorta in control MO- and Vegfc MO-
injected embryos (supplementary material Movies 5, 6). Whereas
the frequency of forward migration or retraction was unchanged
(data not shown), the average magnitude of retraction, but not
forward movement, was significantly greater in ISVs lacking vegfc
compared with the control (Fig. 6D,E). Interestingly, we noted
similar behaviors in simulations of growing tip cells during
competition (compare supplementary material Movie 3 and Movie
4). Thus, vegfc appears to contribute to the persistent forward
migration of ISVs and may also affect filopodial stability during
angiogenesis.
DISCUSSION
Vegfc is an essential regulator of lymphatic vessel development
(Hogan et al., 2009; Karkkainen et al., 2004; Tammela et al., 2008).
However, less is known about its role in developmental
angiogenesis or about the relative importance of distinct Vegfc
domains for its function. Here, we find that vegfc is important for
endothelial tip cell migration during angiogenesis, consistent with
the proposed role of its receptor flt4 (Siekmann et al., 2008). Our
observations further suggest that vegfc functions in an endothelial
cell-autonomous manner in this regard. Indeed, vegfc is expressed
in ISVs as they sprout from the dorsal aorta and mosaic analysis
demonstrates that vegfc-deficient endothelial cells are less likely to
contribute to the tip cell position in ISVs. These results are
consistent with the ISV growth defects observed in rspo1 mutant
zebrafish, which lack endothelial vegfc expression, and can be
rescued with an endothelial cell-specific vegfc transgene (Gore et
al., 2011). Interestingly, ISV tip cells in rspo1 mutant embryos
displayed significantly fewer filopodia, consistent with our
observation that Vegfc contributes to filopodia stability.
Co-expression of flt4 and vegfc in ISVs and the cell-autonomous
requirement for vegfc suggests that a Vegfc/Flt4 autocrine loop is
important to promote tip cell migration and angiogenesis
(supplementary material Fig. S7B). Vascular endothelial growth
factor A (Vegfa) can also act in an autocrine loop to promote
endothelial cell survival (Lee et al., 2007). However, we did not
observe overt indications of apoptosis in vegfc-deficient embryos
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Fig. 5. Endothelial cell-autonomous effects of Vegfc on
angiogenesis. (A-C) Confocal micrographs of trunk blood vessels in
Tg(fli1a:egfp)y1 zebrafish embryos at 30 hpf. Anterior to the left, dorsal is
up. Transgene expression (red fluorescence) is indicated in normal (arrow)
or ectopically branched (arrowheads) ISVs. Embryos were co-injected
with tol2 transposase mRNA and (A) pTol2-fliebs:egfp-2Acherry, (B) pTol2-
fliebs:vegfc-2Acherry or (C) pTol2fliebs:vegfcum18-2Acherry. (D) Quantification
of ectopic ISV branching in cells expressing the fliebs:egfp-2Acherry (n=12
embryos) or fliebs:vegfc-2Acherry (n=18 embryos) transgene. Values
indicate the proportion of embryos with Cherry-positive ISVs displaying
ectopic branching. (E,F) Confocal micrographs of trunk blood vessels at
30 hpf of Tg(kdrl:rasmcherry)s896 host embryos transplanted with
Tg(fli1a:egfp)y1 cells (green) from embryos injected with 5 ng (E) control
MO or (F) Vegfc MO. Arrow indicates a stalk cell. (G,H) The proportion of
embryos displaying donor cells in the indicated trunk vessel position. (G)
Donor cells from embryos injected with the indicated MO. (H) Donor cells
were from embryos derived from an incross of vegfcum18 carriers. *P<0.05;
N.S., not significant; error bars indicate s.e.m. Scale bars: 50 μm.
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(data not shown). Rather, our data suggest that autocrine Vegfc/Flt4
signaling is required for endothelial migration and directional
persistence. Epidermal growth factor (Egf) functions in a similar
manner during epithelial cell migration (Maheshwari et al., 2001),
in which autocrine signaling maintains directional persistence.
Moreover, a truncated form of Egf that is retained within the cell
can promote migration in an intracrine manner. This observation
suggests that the lack of overt angiogenesis defects in vegfcum18
mutant embryos might be due to compensatory intracrine signaling
as the truncated protein would be capable of activating co-expressed
Flt4 within the cell. Indeed, endothelial-expressed vegfcum18 can
induce ectopic ISV branching despite its failure to rescue lymphatic
development, where it acts as a paracrine factor. However, ISV
formation is affected in vegfcum18 embryos lacking either kdrl or
dll4, suggesting that intracrine signaling might not be optimal. An
intracrine mechanism might also explain differences in ISV defects
between vegfcum18 mutants and other examples of vegfc deficiency
in zebrafish, which can more severely affect ISV sprouting (e.g.
vegfc morphants or rspo1 mutant embryos). Although our results
suggest that a Vegfc/Flt4 autocrine loop promotes angiogenesis, we
cannot rule out possible paracrine roles. Indeed, macrophage-
expressed Vegfc is thought to play a central role in postnatal mouse
retinal angiogenesis (Tammela et al., 2011). Thus, further work
using cell type-specific ablation of vegfc will be essential to better
define the signaling modalities in each of these contexts.
The memAgent-Spring computational model has previously
proved insightful for revealing the importance of a Vegf-Notch
feedback loop in modulating endothelial tip and stalk cell behaviors
(Bentley et al., 2008; Bentley et al., 2009). Simulations using this
model correctly predicted that cells within a growing sprout would
continuously compete for the tip cell position and that the ‘winner’
is determined by relative levels of Vegf and Notch (Jakobsson et
al., 2010). However, these simulations had not previously
incorporated Vegfc or its receptor. Our integration of a Vegfc/Flt4
autocrine loop into this model suggested an important role for this
pathway in ISV growth, filopodia stability and directional
persistence. Accordingly, we observed in vivo evidence for the
model-predicted effects on ISV growth by time-lapse analyses.
Although ISV growth defects following Vegfc knockdown were
somewhat milder in vivo than those predicted by the model, these
quantitative discrepancies are expected because the output from the
model simulations is necessarily qualitative; as in most
computational models, the input parameters are clearly limited to
the known factors under investigation in this study. Furthermore,
detailed quantitative values, such as the number of receptor
molecules per cell or receptor/ligand binding affinities, are currently
lacking and so could not be included in the model. Nevertheless,
both the model and in vivo observations point toward an important
role for Vegfc in maintaining filopodia stability and directional
persistence during angiogenesis. Importantly, this mechanism might
not otherwise have been identified without the use of the
memAgent-Spring model and resulting predictions gained from its
application.
Whereas angiogenesis is mildly affected by the um18 mutation,
lymphatic development is severely blocked, with defects even in
heterozygous embryos. These phenotypes are consistent with the
inability of the mutant protein to be efficiently secreted,
underscoring the function of Vegfc as a paracrine factor that directs
lymphatic development. In mouse embryos, Vegfc from
mesenchymal cells adjacent to the cardinal vein promotes the
sprouting of lymphangioblasts (Karkkainen et al., 2004). In
zebrafish, venous sprouts that will give rise to the lymphatic system
likewise grow towards Vegfc, which is expressed in the endothelial
cells of the dorsal aorta. Interestingly, the arterial vasculature in the
zebrafish guides patterning of the developing lymphatic system
(Bussmann et al., 2010). Given that vegfc is specifically expressed
in arterial endothelial cells and that its secretion is essential for
lymphatic development, our results support a model in which
arteries guide the development of nascent lymph vessels, in part,
through the paracrine action of Vegfc (supplementary material Fig.
S7B).
The um18 mutation eliminates the Vegfc C-terminal domain,
which contains tandemly repeated cysteine-rich motifs resembling
those of the silk protein BR3P (Kukk et al., 1996). Domain-swap
studies have demonstrated that the C-terminal domain could
potentiate angiogenic responses when fused to Vegfa (Keskitalo et
al., 2007). Conversely, fusion of the Vegfc VEGF homology domain
(VHD) to the Vegfa C-terminus limited its ability to induce
lymphatic vessel growth when compared with wild-type Vegfc
(Tammela et al., 2007). Whereas these studies suggested a possible
structural role for the Vegfc C-terminal domain within the
extracellular matrix, our work implicates this domain in secretion.
Previous studies reported that the Vegfc VHD alone can be secreted
from cells. Indeed, we observe that Vegfcum18 can eventually be
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Fig. 6. Vegfc is required for directional persistence.
(A) ISV growth in computational simulations of wild-type
or Vegfc MO-injected zebrafish embryos. (B) Difference in
ISV growth rate from two-photon time-lapse analysis of
Tg(fli1a:egfp)y1 embryos injected with 5 ng control or
Vegfc MO. Each time point is an average of 12 (control
MO) or 13 (Vegfc MO) ISVs measured at 5-minute
intervals from at least four embryos. The difference in the
means across all intervals was significant by a paired t-
test (P<0.0001). (C) Filopodia persistence (measured in
minutes). Measurements were derived from 75 filopodia
counted across five control or Vegfc MO-injected
embryos in parallel 50-minute intervals of two-photon
time-lapse movies. (D) Average magnitude of ISV
retraction. Data were obtained from at least 16 separate
ISVs observed in two-photon time-lapse movies of at
least six embryos. **P=0.015. (E) Average magnitude of
ISV forward migration. Data were obtained from the
same ISVs as in D. ns, not significant. Error bars indicate
s.e.m.
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found in the medium from transfected cells. However, there is a
clear defect in secretion and a vegfcum18 transgene is not capable of
rescuing lymphatic development in zebrafish embryos. It is likely
that eventual secretion in cell culture experiments is due to high
levels of transgene expression driven by constitutively highly active
promoters. Furthermore, many constructs from previous studies
contain heterologous secretion signals that might mask the
importance of the C-terminus. Thus, we believe that our results
support an important role for the Vegfc C-terminal domain in
secretion, although the intervening amino acid sequences between
the um18 truncation and the furin cleavage site might also be
important. How these domains act to promote efficient transport
through the secretory apparatus is currently unclear. Given the ease
with which transient rescue experiments can be performed in the
vegfcum18 mutants, it will be possible to further dissect the
importance of this and other domains within Vegfc for its function
during lymphatic development.
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